ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "pregnancy"

  • Abstract Number: 0436 • ACR Convergence 2024

    Family Planning in Rheumatology: A Single Center Quality Improvement Project

    Sara Heard, Elena Cravens, Jeanne Gosselin and Juvena Hitt, University of Vermont Medical Center, Burlington, VT

    Background/Purpose: Pregnancy in patients with rheumatologic disease can lead to serious maternal and fetal complications. Multinational surveys have shown that medical providers often fail to…
  • Abstract Number: 0576 • ACR Convergence 2024

    Less Than 15% Unfavourable Pregnancy Outcomes in Patients with Recent-onset Axial Spondyloarthritis: The Analysis of the 10 Years DESIR Cohort Follow-up

    Madeleine FRANC1, Anne Tournadre2 and Anna Molto3, 1Groupe Hospitalier Cochin, APHP, Paris, France, 2Service de Rhumatologie, centre hospitalier universitaire de Clermont-Ferrand, Université Clermont Auvergne, Clermont-Ferrand, France, 3Groupe Hospitalier Cochin, AP-HP, Paris, France

    Background/Purpose: Only scarce data is available regarding pregnancy outcomes in early axSpA. The objective of this study was to determine (a) the factors associated with…
  • Abstract Number: 1869 • ACR Convergence 2024

    Analysis of Short-Term Side Effects Following COVID-19 Vaccination in Pregnancies Complicated by Autoimmune Inflammatory Rheumatic Diseases

    Shunya Kaneshita1, Christina Chambers2, Diana Johnson1, Arthur Kavanaugh1, Richard Garfein1 and Gretchen Bandoli1, 1University of California San Diego, La Jolla, CA, 2University of California, San Diego, La Jolla, CA

    Background/Purpose: Pregnant women are particularly at risk of severe Coronavirus disease 2019 (COVID-19) infection, which is why the Centers for Disease Control and Prevention (CDC)…
  • Abstract Number: 0437 • ACR Convergence 2024

    Describing Maternal Outcomes Among Veterans with a History of Systemic Lupus Erythematosus and Rheumatoid Arthritis

    Deirdre Quinn1, Florentina Sileanu1, Gregory Procario1, Shannon Mitchell1 and Mehret Birru Talabi2, 1VA Pittsburgh Healthcare System, Pittsburgh, PA, 2University of Pittsburgh, Pittsburgh, PA

    Background/Purpose: Veterans who utilize Department of Veterans Affairs (VA) maternity benefits, nearly half (42%) of whom represent racial or ethnic minority groups, have a high…
  • Abstract Number: 0577 • ACR Convergence 2024

    AMH Titers in Women with Axial Spondyloarthritis Are Significantly Lower Compared to the General Population: An Analysis of the 10-year Follow-up of the DESIR Cohort

    Madeleine FRANC1, Jean Guibourdenche2, Anne Tournadre3 and Anna Molto4, 1Groupe Hospitalier Cochin, APHP, Paris, France, 2Groupe Hospitalier Cochin, APHP, Paris, 3Service de Rhumatologie, centre hospitalier universitaire de Clermont-Ferrand, Université Clermont Auvergne, Clermont-Ferrand, France, 4Groupe Hospitalier Cochin, AP-HP, Paris, France

    Background/Purpose: Data on fertility in women with spondyloarthritis (SpA) is sparse but seems to be impaired compared to the general population. Divergent results have been…
  • Abstract Number: 1893 • ACR Convergence 2024

    Hydroxychloroquine Use in Early Pregnancy and Risk of Preterm Delivery in a Californian Cohort of Lupus Pregnancy

    Amadeia Rector1, Emily Liu2, Miranda Cantu3, Eliza Chakravarty4, Maurice Druzin5, Gary Shaw6, Michael Weisman7, Monique Hedderson2 and Julia Simard8, 1Stanford University, San Francisco, CA, 2Kaiser Permanente Division of Research, Oakland, CA, 3Patient partner, Portage, MI, 4Oklahoma Medical Research Foundation, Oklahoma City, OK, 5Stanford University School of Medicine, Stanford, CA, 6Stanford University School of Medicine, Stanford, 7Stanford University, Los Angeles, CA, 8Stanford School of Medicine, Stanford, CA

    Background/Purpose: Preterm delivery (PTD) occurs 2-3 times more frequently in patients with systemic lupus erythematosus (SLE) compared to the general obstetric population. Hydroxychloroquine (HCQ), a…
  • Abstract Number: 0035 • ACR Convergence 2024

    Anti-CCP Generation in the Female Genital Tract Is Increased During the Postpartum Period in Women Without RA

    Daniele Marcy1, Ashley Visser2, Claudia Lugo2, Kristin Sturm2 and Kristen Demoruelle3, 1University of Colorado Anschutz Medical Campus, Northglenn, CO, 2University of Colorado Anschutz Medical Campus, Aurora, CO, 3University of Colorado Anschutz Medical Campus, Golden, CO

    Background/Purpose: It is well established that women develop RA approximately three times more often than men. In addition, several risk factors for RA uniquely effect…
  • Abstract Number: 0438 • ACR Convergence 2024

    Overweight and Obesity Are Key Modifiable Risk Factors for Adverse Outcomes in SLE Pregnancies

    Jessica Boivin1, Karim Sacre2, Sasha Bernatsky3, Ann E. Clarke4, Megan Barber4, Paul Fortin5, John Hanly6, Alexandra Legge7, Sang-Cheol Bae8 and Evelyne Vinet9, 1McGill University, Montreal, QC, Canada, 2Université de Paris, Paris, France, 3Research Institute of the McGill University Health Centre, Montreal, QC, Canada, 4Division of Rheumatology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, 5Centre ARThrite - CHU de Québec - Université Laval, Quebec, QC, Canada, 6Dalhousie University, Halifax, NS, Canada, Halifax, NS, Canada, 7Dalhousie University, Halifax, NS, Canada, 8Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea, 9McGill University Health Centre, Montreal, QC, Canada

    Background/Purpose: High maternal body mass index (BMI) is a well-established modifiable risk factor for adverse pregnancy outcomes (APO) in the general obstetric population. Best practices…
  • Abstract Number: 0805 • ACR Convergence 2024

    Results from the Certolizumab-pegol Pregnancy Exposure Registry: An OTIS Autoimmune Diseases in Pregnancy Project

    Christina Chambers1, Jane Adams2, Ronghui Xu3, Diana Johnson3, Yunjun Luo3 and Kenneth Jones3, and the OTIS collaborative research group, 1University of California, San Diego, La Jolla, CA, 2Department of Psychology, University of Massachusetts, Boston, MA, 3University of California San Diego, La Jolla, CA

    Background/Purpose: Certolizumab pegol (CZP) is a tumor necrosis factor (TNF) blocker first approved in the U.S. in 2008.  CZP is approved for the treatment of…
  • Abstract Number: 2165 • ACR Convergence 2024

    Fertility Concerns in Adolescents and Young Adults Receiving Gonadotoxic Medications for Rheumatic Disease

    SHAHD FARAJALLAH1, Katie Dunnock2, Qing Yu3, Sangeeta Sule4 and Tova Ronis4, 1Children's national hospital, Washington DC, 2George Washington University, washington dc, 3George Washington University, washington dc, DC, 4Children's National Hospital, Washington, DC

    Background/Purpose: Adolescents and young adults diagnosed with rheumatic diseases often require treatment with teratogenic and cytotoxic medications to effectively manage their conditions. While these therapies…
  • Abstract Number: 0184 • ACR Convergence 2024

    Improving Age Disparities in Contraceptive Counseling in Women with Lupus: A Quality Improvement Initiative

    Hillary Weisleder1, Chinenye Osuorji2, Melissa Fazzari3, Ying Jin2 and Bibi Ayesha2, 1Montefiore Einstein, New York, NY, 2Montefiore Medical Center, Bronx, NY, 3Albert Einstein College of Medicine, Bronx, NY

    Background/Purpose: Lupus is an autoimmune disease primarily affecting women of reproductive age. Lupus confers an increased risk of adverse maternal fetal outcomes, and pre-pregnancy planning…
  • Abstract Number: 0439 • ACR Convergence 2024

    Contraception Counseling and Contraception Use Among SLE and RA/JIA Patients at a Public Medical Center in Los Angeles: Investigating Teratogenic Medication Use and Language Preferences

    Laura Kobashigawa1, Cassidy Hernandez-Tamayo2, Katherine Ruddy3, Melissa Wilson2 and Leanna Wise4, 1University of Southern California/Los Angeles General Medical Center, Pasadena, CA, 2Keck School of Medicine of USC, Los Angeles, CA, 3University of Southern California/ Los Angeles General Medical Center, Los Angeles, CA, 4LAC+USC/Keck Medicine of USC, Pasadena, CA

    Background/Purpose: Systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA)/juvenile idiopathic arthritis (JIA) frequently impact women of reproductive age. Management of these patients is particularly important…
  • Abstract Number: 0806 • ACR Convergence 2024

    Rotavirus Vaccine in Offspring Exposed to Tumour Necrosis Factor Inhibitors During the Third Trimester Does Not Increase Diarrhea-Associated Healthcare Events

    Leah K. Flatman1, Sasha Bernatsky2, Isabelle Malhamé3, Yvan St-Pierre4, Olga Basso1, Anick Bérard5 and Evelyne Vinet3, 1McGill University, Montreal, QC, Canada, 2Research Institute of the McGill University Health Centre, Montreal, QC, Canada, 3McGill University Health Centre, Montreal, QC, Canada, 4McGill University Health Center, Montreal, QC, Canada, 5Université de Montréal, Montreal, QC, Canada

    Background/Purpose: Until recently, best practice guidelines recommended withholding rotavirus vaccine in offspring exposed in utero to any TNFi until 6 months of age due to fears of…
  • Abstract Number: 2398 • ACR Convergence 2024

    The Relationship Between First-Trimester Maternal Serum 25-Hydroxyvitamin D and Maternal/Fetal Outcomes in Patients with Systemic Lupus Erythematosus

    wen zeng1, Yuanyuan zeng1, Lan Zhang2, Cheng Zhao1, Fang Qin1, Leting Zheng2, Mu Huang2 and ling lei1, 1The First Affiliated Hospital of Guangxi Medical University, nanning, China (People's Republic), 2The First Affiliated Hospital of Guangxi Medical University, nanning, Guangxi, China (People's Republic)

    Background/Purpose: To identify whether serum 25-Hydroxyvitamin D (25(OH)D) level in first-trimester(before13 weeks of gestation) maternal is associated with pregnancy outcomes in patients with systemic lupus…
  • Abstract Number: 0361 • ACR Convergence 2024

    Maternal and Fetal Outcomes in Those with Autoimmune Connective Tissue Disease

    Nada Alrifai1, Anushree Puttur2, Laith Alhuneafat3, Fares Ghanem4, yadhu Dhital2, Ahmad Jabri5 and David Feinstein6, 1Cooper University Hospital, Cherry Hill, NJ, 2Allegheny Health Network, Pittsburgh, PA, 3University of Minnesota, Minneapolis, MN, 4Southern Illinois University, Springfield, IL, 5Henry Ford, Detroit, MI, 6Cooper University, Camden, NJ

    Background/Purpose: Autoimmune connective tissue diseases (CTD) predominantly affect women during their reproductive years. CTDs such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and systemic…
  • 1
  • 2
  • 3
  • …
  • 19
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology